Procter & Gamble ($PG) Health Care CEO Paul Gama Receives 12,517 RSUs
PROCTER & GAMBLE Co
Subscribe to track PG
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Form 4 Filing: Procter & Gamble Co ($PG) Insider: Paul Gama (CEO- Health Care) Transaction: Grant of 12,517 shares of Common Stock (RSUs) at $0.00 Direct Holdings Post-Transaction: 53,348.88 shares Significance: Low (Routine equity award)
Comprehensive Analysis
Executive Summary
On October 1, 2026, Paul Gama, Chief Executive Officer - Health Care at Procter & Gamble Co ($PG), was granted 12,517 Restricted Stock Units (RSUs) pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. The award was executed at an acquisition price of $0.00 per share.
Transaction Details
- Date of Transaction: October 1, 2026
- Security: Common Stock
- Transaction Code:
A(Grant, award, or other acquisition pursuant to Rule 16b-3) - Shares Acquired: 12,517 shares
- Price per Share: $0.00
- Direct Ownership After Filing: 53,348.8803 shares
- Indirect Ownership: 1,173.4717 shares held via Retirement Plan Trustee
Market Impact & Significance
This transaction represents a routine annual or milestone equity compensation grant rather than an open-market discretionary purchase or sale. Because the shares were awarded at no cash cost as standard executive compensation, it carries Low trading significance and is unlikely to reflect independent directional sentiment regarding the company's valuation.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.